Exploration of treatment in childhood Langerhans cell histiocytosis based on inflammatory and malignant symptoms: a pilot study
Multisystem childhood Langerhans cell histiocytosis (LCH) patients, especially those with risk organ (RO) involved, had not been satisfactorily treated under the international traditional schemes as high incid...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Hui-ling Lin, Qing-qing Zheng, Ru-lin Huang, Rong Hu, Xiao-dan Liu and Jia-yi Wang Tags: Research Source Type: research
More News: Cancer & Oncology | Histiocytosis | Internal Medicine | Langerhans Cell Histiocytosis (LCH) | Rare Diseases | Study